Navigation Links
RRD Announces Move to New Corporate Headquarters
Date:9/9/2010

ROCKVILLE, Md., Sept. 9 /PRNewswire/ -- RRD International, a strategy-driven biotech and pharmaceutical product development company, announced today that they have moved to expanded offices this month.  The new office space, located at 7361 Calhoun Place, Rockville, MD, recently completed build-out and more than doubles RRD's business footprint to 13,000 sq ft.

"This move is symbolic of the growth and success RRD has achieved in the last year," said Scott Tarrant, Chief Business Officer, RRD International. "Our model has proven time and again to be more efficient and successful than traditional methods, and the market's increasing demand for RRD services necessitated finding a new space to accommodate our growing needs."

RRD International delivers tactical, regulatory-driven product development support to companies and investors in the life sciences industry. Leveraging its in-house strategic and operational expertise, the Company helps clients better plan, manage and execute product development. Having successfully completed more than 80 product development engagements with a wide range of organizations, RRD International's fully integrated development team works to enable rapid proof of concept, reduce costs, and accelerate value creation.

"Times of growth and change are always exciting," added Chuck Finn, President and CEO, RRD International.  "We're thrilled to have found a place that lets us remain in Rockville and better serve our clients and partners."

About RRD International

Founded in 2002, RRD is a strategy-driven product development company. The Company's development model enables rapid proof of concept for biotech and pharmaceutical clients to accelerate value inflection points; reduce costs; and mitigate development as well as execution risk. RRD offers two distinct types of client engagements: TacDev® and DevCo®. The TacDev® model adds development bandwidth and expertise for defined products in companies with minimal infrastructure. The DevCo® model creates external product development companies where investment is in asset optimization rather than traditional infrastructure. For more information visit: www.rrdintl.com. RRD International: Accelerating the Right Development; Creating Lasting Value.


'/>"/>
SOURCE RRD International
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Huifeng Bio-Pharmaceutical Technology, Inc. Announces the Acquisition of Shangqiu Kexin Rutin Processing Ltd.
2. Martek Announces Third Quarter FY 2010 Financial Results
3. ReproCELL Announces New Line of Services in Neuronal Research Using Human iPS Cells
4. Medisafe 1 Technologies Announces 1-5 Stock Dividend
5. DGP Group Rebrands as Intelsius and Announces Launch of New, Innovative Packaging System - Orcatherm™
6. EUSA Pharma Announces the Appointment of Stephen A. Stamp to its Board of Directors
7. Biodel Announces Name Change for Lead Product Candidate
8. Enerkem Announces Construction Start of Worlds First Municipal Waste-to-Biofuels Facility in Edmonton, Alberta
9. MonoSol Rx Announces Reckitt Benckiser FDA Approval of Suboxone® Sublingual Film for Treatment of Opioid Dependence
10. Glenmark Announces the Discovery of a Novel Chemical Entity GRC 17536, a TRPA1 Receptor Antagonist, a Potential First-in-Class Molecule Globally
11. ThermoGenesis Announces Sale of BioArchive Systems In Asia as Company Increases Presence In Key Market
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... 27, 2016  Liquid Biotech USA ... of a Sponsored Research Agreement with The University ... (CTCs) from cancer patients.  The funding will be ... correlate with clinical outcomes in cancer patients undergoing ... then be employed to support the design of ...
(Date:6/24/2016)... ... 24, 2016 , ... While the majority of commercial spectrophotometers and fluorometers use ... 6000i models are higher end machines that use the more unconventional z-dimension of 20mm. ... from the bottom of the cuvette holder. , FireflySci has developed several Agilent ...
(Date:6/23/2016)... CAMBRIDGE, Mass. , June 23, 2016 /PRNewswire/ ... the development of novel compounds designed to target ... compound, napabucasin, has been granted Orphan Drug Designation ... in the treatment of gastric cancer, including gastroesophageal ... cancer stemness inhibitor designed to inhibit cancer stemness ...
(Date:6/23/2016)... MA (PRWEB) , ... June 23, 2016 , ... ... Peel Plate® YM (Yeast and Mold) microbial test has received AOAC Research Institute ... platform of microbial tests introduced last year,” stated Bob Salter, Vice President of ...
Breaking Biology Technology:
(Date:6/3/2016)... Das DOTM (Department ... hat ein 44 Millionen $-Projekt ... einschließlich Personalisierung, Registrierung und IT-Infrastruktur, an Decatur ... Implementierung von Identitätsmanagementlösungen. Zahlreiche renommierte internationale Anbieter ... aber Decatur wurde als konformste und innovativste ...
(Date:6/2/2016)... The Weather Company , an IBM Business (NYSE: IBM ... which consumers will be able to interact with IBM Watson ... or text and receive relevant information about the product or ... long sought an advertising solution that can create a one-to-one ... valuable; and can scale across millions of interactions and touchpoints. ...
(Date:6/1/2016)... 1, 2016 Favorable Government Initiatives ... and Criminal Identification to Boost Global Biometrics System Market ... TechSci Research report, " Global Biometrics Market By ... and Opportunities, 2011 - 2021", the global biometrics market ... on account of growing security concerns across various end ...
Breaking Biology News(10 mins):